Contact Us: 1-518-583-0095 
We’re Hiring… Join Our Team!
Aptium Oncology, Inc. announced the launch of Aptium Oncology Myeloma Consortium (AMyC), a broad-based collaboration that brings together renowned investigators to work with pharmaceutical sponsors to advance clinical and translational research in myeloma and related cancers.
Continue readingAt the 19th IASLC World Conference on Lung Cancer in Toronto, Canada, the top 5 abstracts were presented in the Presidential Plenary Session on Tuesday Sept 25th. Out of the 5 presentations, two were presented by ATOMIC members (Stephen Liu, MD, on Impower 133 and Dr. Ross Camidge, MD, PhD, on ALTA-1L) each of which were supported with an associated synchronous New England of Journal of Medicine publication
Continue readingElena Shagisultanova, MD, PhD, Assistant Professor at the University of Colorado Denver Cancer Center and Lead Principal Investigator of the TULiP trial presented a trials-in-progress poster summarizing the study design for the ongoing trial in patients with hormone receptor positive and HER2-positive (HR+/HER2+) metastatic breast cancer.
Continue reading